Endothal-disodium

Base Information

• Chemical Name: Endothal-disodium
• CAS No.: 53608-75-6
• Molecular Weight: 0.00000
• European Community (EC) Number: 258-659-7,204-959-8
• DSSTox Substance ID: DTXSID1041899
• Nikkaji Number: J48.637J
• Wikidata: Q27155657
• Mol file: 53608-75-6.mol

Synonyms:Cotazym S;Cotazym-S;Cotazyme;Creon;Encron;Ilozyme;Ku Zyme;Ku-Zyme;Lipram;Pancrease;Pancrecarb;Pancrelipase;Pancron;Panokase;Pertzye;Protilase;Ultrase;Viokase;Zymase

Chemical Property of Endothal-disodium

Chemical Property:

• PSA: 0.00000
• LogP: 0.00000
• Hydrogen Bond Donor Count: 0
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 0
• Exact Mass: 230.01671192
• Heavy Atom Count: 15
• Complexity: 224

Purity/Quality:

99%, ^*data from raw suppliers

PANCRELIPASE 95.00% ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

Useful:

• Chemical Classes: Pesticides -> Herbicides, Other
• Canonical SMILES: C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]
• Recent ClinicalTrials: Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor
• Recent EU Clinical Trials: Randomised, Double-Blind, Active-Controlled, Two-Treatment, Crossover,
• Recent NIPH Clinical Trials: A feasibility study of perioperative administration of immunoenhancing enteral nutrients combined with pancrelipase in patients with pancreatoduodenectomy for pancreatic cancer
• Use Description: Pancrelipase, a medication containing digestive enzymes such as amylase, lipase, and protease, has vital applications across various fields. In the pharmaceutical and medical industry, it is primarily used as a digestive aid for individuals with pancreatic insufficiency, such as those with cystic fibrosis or chronic pancreatitis. Pancrelipase plays a critical role in improving the absorption of essential nutrients from food by aiding in the digestion of fats, proteins, and carbohydrates, thus promoting better nutrition and overall health in patients with these conditions. Additionally, in the field of research and clinical trials, Pancrelipase may be used as a tool for studying and understanding pancreatic function, digestive disorders, and the development of therapies related to malabsorption. Its significance lies predominantly in the healthcare sector, where it enhances the quality of life for individuals with pancreatic insufficiency while contributing to advancements in the understanding and treatment of digestive disorders.